VEGFR2/CD309 antibody (pTyr1175)
Quick Overview for VEGFR2/CD309 antibody (pTyr1175) (ABIN2742367)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pTyr1175
-
Specificity
- Recognizes endogenous levels of VEGFR2 (pY1175) protein.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human VEGFR2 (pY1175).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: ICC (1:100 - 1:500), IF, IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Aliquot to avoid freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- KDR / VEGFR2
-
Background
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
Gene ID
- 3791
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-